Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis (2020)
Jesus, Jessica Adriana; Silva, Thays Nicolli Fragoso da; Yamamoto, Eduardo Seiji; Lago, Joao Henrique G; Laurenti, Marcia Dalastra 
; Passero, Luiz Felipe Domingues
Source: Pathogens. Unidade: FM
Subjects: LEISHMANIOSE VISCERAL, LEISHMANIOSE CUTÂNEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Jessica Adriana et al. Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis. Pathogens, v. 9, n. 10, 2020Tradução . . Disponível em: https://doi.org/10.3390/pathogens9100855. Acesso em: 30 jul. 2024.APA
Jesus, J. A., Silva, T. N. F. da, Yamamoto, E. S., Lago, J. H. G., Laurenti, M. D., & Passero, L. F. D. (2020). Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis. Pathogens, 9( 10). doi:10.3390/pathogens9100855NLM
Jesus JA, Silva TNF da, Yamamoto ES, Lago JHG, Laurenti MD, Passero LFD. Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis [Internet]. Pathogens. 2020 ; 9( 10):[citado 2024 jul. 30 ] Available from: https://doi.org/10.3390/pathogens9100855Vancouver
Jesus JA, Silva TNF da, Yamamoto ES, Lago JHG, Laurenti MD, Passero LFD. Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis [Internet]. Pathogens. 2020 ; 9( 10):[citado 2024 jul. 30 ] Available from: https://doi.org/10.3390/pathogens9100855
